Sorting nexin 2 (Nexin-2, SNX2, TRG9) (C-Term) antibody
| Antigen | Sorting nexin 2 (Nexin-2, SNX2, TRG9) |
| Binding Site |
C-Term |
| Clonality | Polyclonal |
| Host |
Rabbit |
| Application |
Immunohistochemistry (IHC), Western Blotting (WB)
|
![]() |
5 references available |
| Catalog no. | ABIN350874 |
| Quantity | 100 µl |
| Price | 454.67 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 7 to 8 Business Days |
Additional Information
| UniProt | O60749 |
| Immunogen | A synthetic peptide from the c-terminal of human Sorting nexin 2 (Nexin-2, SNX2, TRG9) conjugated to an immunogenic carrier protein was used as the immunogen. The antigen is homologous in rat and mouse. |
| Format | Lyophilized |
| Description | FUNCTION: May be involved in several stages of intracellular trafficking. Component of the retromer complex, a complex required to retrieve lysosomal enzyme receptors (IGF2R and M6PR) from endosomes to the trans-Golgi network. Also known as: Nexin-2, SNX2, Transformation-related gene 9 protein, TRG-9, TRG9. |
| Specificity | Appears to be specific for Sorting nexin 2. |
Application Details
| Application Notes | IHC, WB (confirmed by recombinant protein). A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not tested in other applications. |
| Purity | whole serum |
| Storage | Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
| Restrictions | For Research Use only |
Publications
|
Haft, de la Luz Sierra, Barr et al.: "Identification of a family of sorting nexin molecules and characterization of their association with receptors." in: Molecular and cellular biology, Vol. 18, Issue 12, pp. 7278-87, 1998 (PubMed).
Fuchs, Rehkamp, Haas et al.: "The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 15, pp. 8756-61, 2001 (PubMed). Beausoleil, Jedrychowski, Schwartz et al.: "Large-scale characterization of HeLa cell nuclear phosphoproteins." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 33, pp. 12130-5, 2004 (PubMed). Beausoleil, Villén, Gerber et al.: "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." in: Nature biotechnology, Vol. 24, Issue 10, pp. 1285-92, 2006 (PubMed). Dephoure, Zhou, Villén et al.: "A quantitative atlas of mitotic phosphorylation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 31, pp. 10762-7, 2008 (PubMed). |
|




